16 articles for P Holzer
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
9
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach.
Novartis Institutes For Biomedical Research
11
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors.
Novartis Institutes For Biomedical Research
20
Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors.
Novartis Institutes For Biomedical Research
16
2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors.
Novartis Institutes For Biomedical Research
13
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field.
Novartis Institutes for Biomedical Research
17
Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360.
TBA
13
Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach.
Novartis Institutes For Biomedical Research
11
In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor.
Novartis Institutes For Biomedical Research
23
Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors.
Novartis Institutes For Biomedical Research
79
Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors
Merck Sharp & Dohme
22
A facile one-pot synthesis of 2-arylamino-5-aryloxylalkyl-1,3,4-oxadiazoles and their urease inhibition studies.
Mirpur University of Science and Technology (Must)
6
Identification and characterization of new inhibitors of fungal homoserine kinase.
Mcmaster University